Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast…

Most women (85 per cent) would back the idea of more frequent breast screening if they are at higher genetic risk of developing…

In Germany, the invitation to undergo mammography screening that is sent to all women between the ages of 50 and 69 is accompanied by an information…

Breast cancer patients who undergo a mastectomy should receive subsequent radiation treatment if their cancer has spread to four or more nearby lymph…

The “Jewels in our Genes” study, led by University at Buffalo researcher Heather Ochs-Balcom, has uncovered previously unknown segments of DNA shared by African American family…

The “Jewels in our Genes” study, led by University at Buffalo researcher Heather Ochs-Balcom, has uncovered previously unknown segments of DNA shared by African American…

A new study led by José Javier Bravo-Cordero, Spanish researcher at the Albert Einstein College of Medicine in New York, details how cells with low levels of the profilin…

UT Southwestern Medical Center scientists have identified a strong link between the most aggressive type of breast cancer and a gene that regulates…

Some older women with breast cancer could safely avoid radiotherapy, without harming their chances of survival, a study has shown.

Older women with early breast cancer who are…

Biologists working with engineers and physicists have found a molecule they say helps determine if breast cancer cells that are resistant to antiestrogen therapy will…

Researchers from Dartmouth’s Norris Cotton Cancer Center, led by Casey S. Greene, PhD, reported in Pacific Symposium on Biocomputing on the use of denoising autoencoders (DAs) to…

A new study identifies a gene that is especially active in aggressive subtypes of breast cancer. The research suggests that an overactive BCL11A gene drives triple-negative breast cancer development and progression.

The…

Researchers at Columbia University’s Mailman School of Public Health in partnership with the New York City-based, not-for-profit Cook for Your Life initiative have published the…

Breast cancer is the most frequent cause of death among women worldwide, and five-year survival rates are just 58.4% in Brazil, lower than in many other regions. In a…

A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast…

VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National…

A new analysis has found that while clinical trial data support omitting radiation treatments in elderly women with early stage…

Women over the age of 70 who have certain early-stage breast cancers overwhelmingly receive radiation therapy despite published evidence that the treatment has limited benefit, researchers at…

Women with a mental illness (including depression, anxiety and serious mental illnesses) are less likely to be screened for breast cancer, according to new research published in the BJPsych…

A study combining tumor cells from patients with breast cancer with a laboratory model of blood vessel lining provides the most compelling evidence so far…

Invisible tattoos could replace the permanent dark ink tattoos used to ensure that breast cancer patients having radiotherapy are treated in exactly the same spot during each…

Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor - positive tumors, about one-half of patients fail to take their medications…

It is an intricate network of activity that enables breast cancer cells to move from the primary breast tumor and set up new growths in other…

Stroma cells are derived from connective tissue and may critically influence tumour growth. This knowledge is not new. However, bioanalyst Christopher Gerner and an interdisciplinary team from the University…

After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival…